Paper59012
Immunisation against hepatitis B in man.
Maupas P and 4 others. Lancet, 1976. Cited by 188 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Immunisation against hepatitis B in man. Papers, record 59012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/59012
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Hepatitis B Antigens | Major topic |
| Vaccination | Major topic |
| Viral Vaccines | Major topic |
| Animals | |
| Humans | |
| Liver | |
| Pan troglodytes |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 188 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,210,771 | Hepatitis B virus infection after immunization: How serious it is? An updated review. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40210771 | PubMed |
| 39,861,834 | Unveiling the Molecular Architecture of HBV Spherical Subviral Particles: Structure, Symmetry, and Lipid Dynamics. | Viruses | 2024 | https://conductscience.org/library/papers/39861834 | PubMed |
| 39,281,486 | An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination. | Heliyon | 2024 | https://conductscience.org/library/papers/39281486 | PubMed |
| 38,675,820 | Hepatitis B Vaccine: Four Decades on. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38675820 | PubMed |
| 37,400,485 | Determining buffer conditions for downstream processing of VLP-based recombinant hepatitis B surface antigen using multimodal resins in bind-elute and flow-through purification modes. | Sci Rep | 2023 | https://conductscience.org/library/papers/37400485 | PubMed |
| 35,409,035 | Apolipoprotein E, a Crucial Cellular Protein in the Lifecycle of Hepatitis Viruses. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409035 | PubMed |
| 35,015,108 | [Hepatitis B vaccines-history, achievements, challenges, and perspectives]. | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | 2022 | https://conductscience.org/library/papers/35015108 | PubMed |
| 32,937,642 | Finding the key to solving problems in the hepatitis kingdom: A Study on the Development of Hepatitis B Vaccine by Kim Chung Young in the 1960-70s. | Uisahak | 2020 | https://conductscience.org/library/papers/32937642 | PubMed |
| 32,759,756 | Advances with RNAi-Based Therapy for Hepatitis B Virus Infection. | Viruses | 2020 | https://conductscience.org/library/papers/32759756 | PubMed |
| 31,973,017 | Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms. | Viruses | 2020 | https://conductscience.org/library/papers/31973017 | PubMed |
| 30,945,969 | B-cell restriction - an alternative piece to the puzzle. | Hum Vaccin Immunother | 2019 | https://conductscience.org/library/papers/30945969 | PubMed |
| 28,511,068 | Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000. | Stud Hist Philos Biol Biomed Sci | 2017 | https://conductscience.org/library/papers/28511068 | PubMed |
| 28,468,285 | Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks. | Viruses | 2017 | https://conductscience.org/library/papers/28468285 | PubMed |
| 27,157,411 | Vaccine technologies: From whole organisms to rationally designed protein assemblies. | Biochem Pharmacol | 2016 | https://conductscience.org/library/papers/27157411 | PubMed |
| 26,978,406 | Hepatitis Vaccines. | Vaccines (Basel) | 2016 | https://conductscience.org/library/papers/26978406 | PubMed |
| 26,097,629 | [Prevalence of hepatitis B in people infected with HIV in Parakou in Benin]. | Pan Afr Med J | 2015 | https://conductscience.org/library/papers/26097629 | PubMed |
| 25,523,195 | Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. | Med Microbiol Immunol | 2015 | https://conductscience.org/library/papers/25523195 | PubMed |
| 24,310,062 | DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques. | Cancer Gene Ther | 2013 | https://conductscience.org/library/papers/24310062 | PubMed |
| 23,870,415 | Medical virology of hepatitis B: how it began and where we are now. | Virol J | 2013 | https://conductscience.org/library/papers/23870415 | PubMed |
| 23,577,080 | A mouse model for studying the clearance of hepatitis B virus in vivo using a luciferase reporter. | PLoS One | 2013 | https://conductscience.org/library/papers/23577080 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/59012
GET https://conductscience.org/api/papers/v1/59012/cited_by?page=2